Decreased serum neurotrophin 3 in chronically medicated schizophrenic males
Section snippets
Acknowledgements
Clarissa Severino Gama is funded by CNPq (PDE #200310/2007-0), Brazil, and Endeavour Awards Programme (#539/2008), Australia.
References (52)
- et al.
Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders
Med. Hypotheses
(2000) - et al.
Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes
Neurosci. Lett.
(2006) - et al.
Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses
Schizophr. Res.
(2001) - et al.
Pathways leading to apoptopic neurodegenration folowing trauma to the developing rat brain
Neurobiol. Dis.
(2002) - et al.
Differential actions of neurotrophins in the locus coeruleus and basal forebrain
Exp. Neurol.
(1993) - et al.
Brain derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons
Mol. Cell. Neurosci.
(1992) - et al.
Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder
Neurosci. Lett.
(2007) - et al.
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine
Progr. Neuropsychopharmacol. Biol. Psychiatry
(2006) - et al.
Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males
Neurosci. Lett.
(2008) - et al.
Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness
Psychiatry Res.
(1997)
Association of neurotrophin-3 gene variant with severe forms of schizophrenia
Biochem. Biophys. Res. Commun.
(1995)
Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients
J. Psychiatr. Res.
(2006)
Allostatic load in bipolar disorder: implications for pathophysiology and treatment
Neurosci. Biobehav. Rev.
(2008)
NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression
Neuron
(1990)
Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations
Genomics
(1991)
Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients
Schizophr. Res.
(2006)
Permeability of the blood–brain barrier to neurotrophins
Brain Res.
(1998)
Permeability at the blood–brain and blood–nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF
Mol. Brain Res.
(1996)
Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis
Biochem. Biophys. Res. Commun.
(2007)
Monocytes of allergics and non-allergics produce, store and release the neurotrophins NGF, BDNF and NT-3
Regul. Pept.
(2005)
The endogenous survival promotion of axotomized rat corticospinal neurons by brain-derived neurotrophic factor is mediated via paracrine, rather than autocrine mechanisms
Neurosci. Lett.
(2000)
Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls
Neurosci. Lett.
(2003)
Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics
Neurosci. Lett.
(2005)
Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder
Neurosci. Lett.
(2007)
Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics
J. Psychiatr. Res.
(2007)
Differential influence of BDNF and NT3 on the expression of calcium binding proteins and neuropeptide Y in vivo
Neuroreport
(2003)
Cited by (0)
Copyright © 2008 Published by Elsevier Ireland Ltd.